COURTNEY SIMS: Open Payments
NPI 1881227759 · ELLISVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 65 payments from 18 companies in 2025. Trend: 2023 $216 · 2024 $1,123 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 10 | $211 |
| ABBVIE INC. | 13 | $179 |
| PFIZER INC. | 12 | $167 |
| Lilly USA, LLC | 6 | $98 |
| Lundbeck LLC | 3 | $59 |
| SK Life Science, Inc. | 2 | $56 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
Products named: NUPLAZID, NURTEC ODT, QULIPTA, KISUNLA, VYEPTI, INSPIRE, REXULTI, KESIMPTA.
Industry payments across MS — which companies pay providers there.
